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Two individuals undergoing orthotopic hepatic 
transplantation received livers from donors who 
were on average 10 kg smaller than themselves 
based on recipient ideal body weight. As a result, the 
donor livers in these 2 cases were 29%-59% smaller 
than would be expected had the donor Ih'er and 
recipient been matched ideally. The liver grafts in 
the recipients steadily increased in size, as deter-
mined by serial computed tomography scanning, to 
achieve new volumes consistent with those that 
would have been expected in a normal individual of 
the recipient's size, sex, and age. Fasting plasma 
levels of amino acids, glucagon, insulin, and stan-
dard liver injury tests were monitored to determine 
which measure best reflected the changes observed 
in the size of the grafts over time. No relationship 
between the changes observed in any of these pa-
rameters and hepatic growth was apparent. In both 
cases, the liver increased in volume at a rate of -70 
mllday. These data demonstrate that a small-for-size 
liver transplanted into a larger recipient increases in 
size at a rate of -70 ml!day until it achieves a liver 
volume consistent with that expected giren the 
recipient's size, age, and sex. 
Under normal circumstances. attempts at matching 
the recipient of an orthotopic liver transplant (OL T) 
with the best available donor in terms of organ and 
body size are made (1,2). Occasionally, however, 
only a small donor is available and thus a small·for-
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size liver is transplanted urgently into a recipient 
who is considerably larger but is in serious need of I 
transplant. In the last 5 yr, we have had 2 cases in 
which a small donor liver has been transplanted into 
a larger recipient. In both cases, we have had the 
opportunity to observe the change in size of the 
allograft over time using serial computed tomogra-
phy (eT) scans to evaluate change in graft size. In 
addition. in each case, we serially obtained measures 
of hepatic injury, plasma amino acids. and circulat· 
ing levels of insulin and glucagon, the two pancre-
atic hormones that are thought to be trophic for the 
liver. Herein are reported the observations made on 
these unique cases . 
Patients and Methods 
Recipients 
The two OLT recipients reported herein had bet-n 
selected as candidates for OL T based on standard criieria 
used in Pittsburgh for establishing such candidacy. Thest 
have been reported elsewhere (1.3-5). For each recipient 
the nature of the primary hepatic disease. body wei~fg~K 
ideal body weight, age. sex. and liver volume obtained b) 
CT scanning before OL T are reported in Table 1. 
Donors 
The two donors had a mean age of 8 yr (range ?-f 
yr). Their body weights. ideal body weights, and hy~ 
volumes are shown in Table 2 . 
Controls 
Eight adult patients undergoing OLT but rec~i~~ 
normal-sized livers served as the controls. Each reeen 
--
---------------:-:::=. pt:\. 
Abbreviations used in this paper: CT, computed tomogrt • 
OLT. orthotopic liver transplant. 
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Table 1- Characteristics of the Two Recipients Studied 
Underlying Liver Body Ideal body 
Ca~e hepatic Age volume weight weight 
:-;" C:,·x disease (ye) (ml) (kg) (kg) 
Primary biliary 44 1768 47.5 56.3-62.7 
cirrhosis 
2 M Postnecrotic 16 1785 44.3 67.3-72.7 
cirrhosis 
li\'er that was no greater or smaller than a liver (:!: 15%) that 
\"ould have been expected to be in the recipient had the 
recipient been normal. 
er Volume Determinations 
J he volume of each recipient's original diseased 
organ before OLT and the recipient's new organ after 
successful OL T was determined serially using a CT scan-
ning technique that has been described and validated 
preYiously (2); liver weights and volumes determined by 
this method are similar on a gram per milliliter basis. 
Hormone Measurements 
, . 15ma immunoreactive insulin. glucagon, and C-
pept ere determined serially after successful OL T at 
the tillle of each CT scan using radioimmunoassay kits 
obtained from Serono Laboratories (Boston. Mass.). The 
detection limits for the three kits are 5,0 Jl'u/ml, 10 pg/ml. 
and 0.2 ng/ml. respectively. Normal values for each are as 
follows: insulin 2-18 JlUlml, glucagon 0-85 pg/ml. and 
(-peptide 0.3-3.0 ng/ml. All measurements were made in 
triplicate and the mean value was reported for each deter-
mination at each time point. 
ndard Laboratory Data 
; uta] bilirubin a'1d aspartate aminotransferase Ie\,-
els were determined daily on venous blood by the Clinical 
Chemistry Division of the Department of Pathology, Pres-
b\'terian University Hospital. using standard methods, 
tasting plasma amino acid levels were determined in 
\enous blood obtained in the morning of the day on which 
~Och CT scan study was obtained. The plasma was sepa-
rut"rl by centrifugation at 4°C and plasma proteins were 
rf'mm· .. 1\' precipitation with 4% sulfosalicylic acid. The 
1"'\'eJ .he individual amino acids were determined 
:>!ng " ,)eckman amino acid analyzer (Beckman Spinco. 
Palo Alto, Calif.). Results were reported as micromoles per 
ceciliter and the molar ratio of the sum of the aromatic 
~mino acids. phenylalanine and tyrosine. to the sum of the 
:Jranched chain amino acids. leucine, isoleucine, and 
\aline, was determined. 
T,]ble :: Characteristics of the Two Donors Studied 
-
Case 
Liver Body Ideal body 
Cause of Age volume weight weight 
:\0. Sex death (yr) (ml) (kg) (kg) 
- M Accident 7 693 23.0 21.0-25.0 
2 F Accident 9 1193 30.0 25.0-33.3 
-
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Figure 1. Liver yyDei:~ID "rams i.1. :::1d liver weight in grams 
corrected : ~: : . ::' weight i~ kilograms (B) for women 
aged 16-",. :;:rouped i~ R-~q intervals. The bars 
represent ::-,-,' "alues. T:-.c- brackets represent the 
standard v: -,' ',: the mea:-. :\ote that liver size in· 
creases ur.· .. I~" ::6-30 anc :hen achieves a plateau. 
Determina:: : - Jf Normal Liver Weight for a 
Given Indi· .. : _ J1 Using .--\ge- and 
Sex-Match,,:: -= Jntrois 
The record5 '.' ·K~e Allegheny County Coroner's 
Office were used:~ :'::1tify indidduals who had died 
suddenly of an ace: >::.: or homicide and who had no 
hepatic pathology a: -...::. .. ,: :ime of their death. The records of 
the individuals meE--':' - :- these criteria were reviewed and 
verified. Forty such ::: :_ ';iduals for each age group (21-25. 
26-30, 31-35. 36--40 ~ >45. and ~S-RM yr) were selected 
for each sex to serVE: -=..: :ontrol data for the determination 
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FigufP 2. Liver weight in grams (AJ and liver weight in grams 
corrected for body weight in kilograms (Bl for men aged 
16-50 yr grouped in 5-yr intervals. The bars represent 
mean values. The brackets represent the standard error 
of the mean. ~ote that as was the case in women. a 
plateau in Ii \'er mass is reached after age 26 yr. 
of normal hepatic weight (volume) for each age group 
(Figures 1 and 2). 
Statistical Analysis 
The rate and amount of growth of the transplanted 
livers was calculated from serial CT volume measurements 
using linear regression analysis. Only successive points 
that showed an increase in Ii ver volume of at least 50 ml 
were used for these calculations to avoid using points 
obtained after the transplanted liver had reached a plateau 
in size. 
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Results 
The data obtained for normal liver weight for 
each sex at 5-yr intervals between ages 21 and 50 yr 
are shown in Figures 1 and 2. 
The small-far-size intact donor organs trans-
planted into the larger recipients grew rapidly over a 
2-3-wk period within their new hosts. The rate of 
hepatic growth in each recipient varied only slightly 
and was linear at an approximate rate of 70 mllday 
until a new hepatic mass was achieved at 10-20 days 
posttransplantation (Figure 3). 
There was no correlation between laboratory mea-
surements of liver injury (bilirubin, transaminases) 
obtained before or immediately after transplantation 
and either the absolute change in liver mass or the 
rate of change in liver mass (data not shown). 
The molar ratio of aromatic amino acids to 
branched chain amino' acids in the serum of the 
recipients studied before OLT was increased; the 
ratio declined initially after liver transplantation, 
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Figure 3. Growth of an intact small-for-size normal liver trans-
planted into a larger recipient. The changes observed in 
graft size for the 2 cases reported are shown in the 
component parts of the figure. The ordinate for each 
component graph is milliliters of liver determined by 
CT scanning. The number in the left upper corner of 
P8ch figure . .;flects the patient number referred to in the 
text. 
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Figure 4. Schematic figure showing the sequential changes in the 
ratio of aromatic amino acids to branched chain amino 
acids. insulin, C-peptide. and glucagon levels in case 1. 
but returned to an elevated level several days 
posttransplantation (Figures 4 and 5). The changes 
observed in this measure did not correlate with 
either the absolute change or rate of change in liver 
mass noted in the recipients. The plasma levels of 
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Figure 5. Schematic figure showing the sequential changes in the 
ratio of aromatic amino acids to branched chain amino 
acids, insulin, and glucagon levels in case 2. 
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Figure 6. Schematic figure showing the sequential changes in the 
ratio of AAA to BCAA. insulin. C-peptide, and 
glucagon in 8 patients undergoing OL T but not having 
a mismatch in terms of liver size. The shaded area is 
the range for normal individuals; the brackets represent 
the SEM. The asterisk in panel B represents the single 
point at which it was statistically different [p < 0.05) 
from that observed at time zero. In panel C, a single 
asterisk indicates p < 0.005, a double asterisk indicates 
p < 0.05. and a cross indicates p < 0.01 from that 
obtained at time zero. In panel D the asterisk identifies 
the two times at which the glucagon level was signifi-
cantly different from the level obtained at time zero. In 
panel A. all points obtained after time zero are signifi-
cantly different from the data obtained al time zero. 
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insulin, C-peptide, and glucagon observed at various 
times before and after OLT in the 2 patients studied 
are shown in Figures 4 and 5. Note that in each case. 
glucagon levels were initially elevated and remained 
elevated posttransplantation, whereas insulin levels 
declined toward normal levels with time after trans-
plantation: note also that the time-course of these 
hormonal changes varied considerably. Similar stud-
ies performed in 8 OL T patients not receiving an 
organ mismatched for size (i.e., within ±15% of 
ideal size) are shown in Figure 6. 
Discussion 
The data presented clearly demonstrate that a 
small-far-size intact liver transplanted into a larger 
host increases in size rapidly over 2-3 wk to achieve 
a size consistent with that of a normal-sized liver in 
a normal individual of the same size, age, and sex as 
the recipient. Several mechanisms may be at least 
partially responsible for this observation. In each 
case, the small dOllar liver was likely subjected to a 
relatively high volume of portal venous blood flow 
after transplantation into a larger recipient. This 
increase in hepatic blood flow relative to liver size 
could be hypothesized to have produced hepatocel-
lular edema; the fact that the transplanted liver 
maintained its new \'olume during the 1-2 wk of 
observation after the plateau in volume was reached 
suggests, however, that the apparent growth of the 
allograft was not due simply to edema. It is also 
possible that increases in the hepatic content of 
glycogen. fat. or inflammatory cells (due to mild 
rejection) may have contributed to the increase in 
liver mass observed after transplantation in these 
two recipients. This possibility may account, at least 
in part. for the increased liver weightlbody weight 
ratio observed in these recipients after successful 
transplantation. Again, the fact that the liver volume 
stabilized at the larger volume achieved 2-3 wk after 
OLT makes this possibility less likely but does not 
rule it out. Moreover. comparable evidence for sta-
bilization of newly increased liver volume in ani-
mals after transplantation of a small-for-size graft 
into a larger recipient has been reported elsev,here 
(6). These observations also make this hypothesis 
less likely. A remaining possibility is that hepatic 
regeneration occurred and accounted for the change 
in liver volume in the small-for-size allograft recip-
ient. 
The changes observed in serum bilirubin. amino-
transferase levels, and the ratio of aromatic amino 
acids to branched chain amino acids after OLT did 
not correlate with the observed changes in hepatic 
mass of the allograft. In addition, as the hepatic mass 
increased and normal liver function returned after 
GASTROENTEROLOGY Vol. 93. No.6 
aLT. the preexistent abnormalities in th~ systemic 
plasma levels of insulin and C-peptide associated 
with cirrhosis and liver failure corrected at least 
partially. In contrast. glucagon levels continued to be 
increased and remained so as the small-for-size 
donor organ increased in size in the larger recipient. 
It must be noted. however. that similar changes were 
observed in the plasma of the 8 patients who did not 
receive mismatched livers; thus it is unlikely that the 
changes observed in the levels of these biochemical 
markers were directly responsible for the hepatic 
growth observed. 
Of the two pancreatic hormones measured. the 
glucagon levels more accurately reflected a putative 
hepatic regeneration stimulus. as demonstrated by 
concomitantly increasing glucagon levels and liver 
volume. These data suggest the possibility that the 
factors that regulate glucagon secretion may regulate 
the process of hepatic regeneration under appropri-
ate circumstances or be a signal for hepatic regener-
ation initiated by some other immediate cause. It is 
also important to note that. although the insulin 
levels declined after successful OLT, insulin extrac-
tion from the portal venous blood was not deter-
mined and hepatic insulin extraction may have been 
increased and have produced the net reduction in 
the plasma levels of the hormone measured. inde-
pendent of the secretion rate of the hormone ac-
cessed by measurement of plasma C-peptide levels. 
Considerable experimental data exist for the con-
cept that both insulin and glucagon are hepa-
totrophic factors (7-25). Each has been shown to 
enhance the nuclear labeling of hepatocytes with 
tritrium-labeled thymidine both in vitro and in vivo 
after partial hepatectomy. Moreover. it has been 
reported that after partial hepatectomy, plasma lev-
els of glucagon increase while the plasma levels of 
insulin fall. and that the turnover rates of both 
insulin and glucagon decrease almost twofold (13. 
14.20,21). Coincidentally. hepatic insulin receptor 
content has been shown to increase twofold, 
whereas hepatic glucagon receptor content declines 
by 50% under these conditions (8,14,25). In addi-
tion. numerous studies performed in both experi-
mental animals and humans after portacaval shunt-
ing procedures have provided considerable evidence 
that insulin acts as a potent hepatotrophic substance 
(8-10,12-21,23-27). Specifically. the liver atrophies 
rapidly after portal vein diversion despite a threefold 
to fourfold increase in the systemic level of insulin 
(15,16.21,22.28). The unique hepatotrophic effect of 
insulin has been documented even more clearly in 
"double liver" experiments in which one side of the 
liver has been perfused via the portal vein with its 
greater insulin levels while the other side receives 
systemic venous blood with its lower insulin content 
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(9). Even the more recent observations that multiple 
factors other than insulin, particularly a host of 
insulinlike peptides, act as hepatotrophic factors do 
nc ~gate the central role of insulin as a hepa-
tot! ,Jhic factor (23,24,29,30). This concept has been 
demonstrated best by the studies in which hepatic 
regeneration occurs in the absence of all splanchnic 
viscera if exogenous insulin is added to the portal 
\'enoUS blood (23,24). 
Taken together, the present data and that of many 
others suggest that there may be an ideal hepatic 
mass for adults of each age and sex and that when 
sur" hepatic mass is achieved, the putative signals 
fa; l)atic regeneration are either turned off or 
coull:erregulatory signals are initiated to inhibit the 
regenerative process. The specific nature of these 
signals, however. has not been elucidated and re-
mains to be determined . 
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